Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis.
Clarissa N PacynaMadhanagopal AnandapadamanabanKevin W LoudonIain M HayOlga PerisicRuoyan LiMatthew ByrneLaura AllenKirsty RobertsYvette HooksAnne Y WarrenGrant D StewartMenna R ClatworthySarah A TeichmannSam BehjatiPeter J CampbellRoger L WilliamsThomas J MitchellPublished in: Oncogene (2024)
Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the wide dissemination of cells predisposed to disease within mature organs. We characterised the evolutionary history of four synchronous renal tumours from a 14-year-old girl using whole genome sequencing alongside single cell and bulk transcriptomic sequencing. Phylogenetic reconstruction timed the origin of all tumours to a multipotent embryonic cell committed to the right kidney, around 4 weeks post-conception. Biochemical and structural analysis of their shared MTOR mutation, absent from normal tissues, demonstrates enhanced protein flexibility, enabling a FAT domain hinge to dramatically increase activity of mTORC1 and mTORC2. Developmental mutations, not usually detected in traditional genetic screening, have vital clinical importance in guiding prognosis, targeted treatment, and family screening decisions for paediatric tumours.
Keyphrases
- single cell
- induced apoptosis
- rna seq
- cell cycle arrest
- emergency department
- cell proliferation
- genome wide
- endoplasmic reticulum stress
- intensive care unit
- adipose tissue
- gene expression
- oxidative stress
- cell death
- drug delivery
- signaling pathway
- dna methylation
- cell therapy
- copy number
- binding protein
- small molecule
- combination therapy
- replacement therapy